| miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4 MRMH Azar, H Aghazadeh, HN Mohammed, MRS Sara, A Hosseini, ... International immunopharmacology 92, 107355, 2021 | 43 | 2021 |
| A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19) RN Mohammed, R Tamjidifar, HS Rahman, A Adili, S Ghoreishizadeh, ... Cell Communication and Signaling 20 (1), 79, 2022 | 31 | 2022 |
| Heat shock proteins regulating toll-like receptors and the immune system could be a novel therapeutic target for melanoma N Shomali, LS Hatamnezhad, S Tarzi, R Tamjidifar, H Xu, SS Shotorbani Current molecular medicine 21 (1), 15-24, 2021 | 28 | 2021 |
| Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations R Tamjidifar, M Akbari, S Tarzi, M Sadeghzadeh, M Abolghasemi, ... Journal of gastrointestinal cancer 52, 125-129, 2021 | 20 | 2021 |
| Dysregulation of miR-27a and SMAD2 can be a reliable indicator in the prognosis and diagnosis of CRC as well as in response to chemotherapy drugs MRMH Azar, M Akbari, HN Mohammed, M Asadi, D Shanehbandi, ... Gene Reports 21, 100844, 2020 | 12 | 2020 |
| HSP90 inhibitor modulates HMGA1 and HMGB2 expression along with cell viability via NF-KB signaling pathways in melanoma in-vitro N Shomali, F Marofi, S Tarzi, R Tamjdidfar, M Akbari, S Parvari, ... Gene Reports 24, 101205, 2021 | 10 | 2021 |
| Anastasis: cell recovery mechanisms and potential role in cancer RN Mohammed, M Khosravi, HS Rahman, A Adili, N Kamali, ... Cell Communication and Signaling 20 (1), 81, 2022 | 9 | 2022 |
| A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview A Saburi, MS Kahrizi, N Naghsh, H Etemadi, A İlhan, A Adili, ... Journal of Ovarian Research 15 (1), 81, 2022 | 7 | 2022 |
| Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro HA Alkafaji, A Raji, HS Rahman, AO Zekiy, A Adili, M Jalili, T Hojjatipour, ... Journal of cellular and molecular medicine 25 (14), 6864-6873, 2021 | 7 | 2021 |
| Inhibition effect of Hsp90 on TLR2, TLR4, and MAPK signaling pathway in melanoma in-vitro S Tavakoli, A Adili, M Akbari, R Tamjidifar, S Tarzi, M Saadat, ... Gene Reports 24, 101234, 2021 | 4 | 2021 |
| A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review F Sharafi, SA Hasani, S Alesaeidi, MS Kahrizi, A Adili, S Ghoreishizadeh, ... Cancer Cell International 22 (1), 269, 2022 | 3 | 2022 |
| Under hypoxic conditions, MSCs affect the expression and methylation level of survival‐related genes in ALL independent of apoptosis pathways in vitro F Marofi, N Shomali, LA Younus, A Hassanzadeh, G Vahedi, ... Biotechnology and Applied Biochemistry 69 (2), 822-839, 2022 | 3 | 2022 |
| Potential anti-inflammatory effect of anti-HMGB1 in animal models of ICH by downregulating the TLR4 signaling pathway and regulating the inflammatory cytokines along with … J Xu, SM Firouz, M Farrokhian, S Ghoreishizadeh, TAM Mohamad, ... European Journal of Pharmacology 915, 174694, 2022 | 3 | 2022 |
| Boosting T cell numbers to fight COVID-19 RN Mohammad, R Tamjidifar, HS Rahman, A Adili, S Ghoreishizadeh, ... | | 2023 |
| Anastasis: How cancer cells cheat death RN Mohammed, M Khosravi, HS Rahman, A Adili, N Kamali, ... | | 2023 |
| Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro X Yang, Y Wang, HS Rahman, TAM Mohammad, AD Sorkhabi, ... Medical Oncology 39 (7), 88, 2022 | | 2022 |
| Boosting T cell numbers to fight COVID-19 (preprint) RN Mohammad, S Danshina, HS Rahman, A Adili, S Ghoreishizadeh, ... | | 2022 |
| Frequency of Hepatitis C Virus Genotypes in Patients Who Had Hepatocellular Carcinoma in Gastroenterological Hospitals of Tabriz S Tarzi, M Mansouri, SP Sarand, N Shomali, R Tamjidifar, ... Journal of Gastrointestinal Cancer 52, 145-149, 2021 | | 2021 |
